Pallas Capital Advisors »

Neumora Therapeutics shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $13k 13k 1.00

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Microsoft Corporation (MSFT)
Global Partners Com Units (GLP)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Fundamental Intl (FNDF)
Dimensional Etf Trust Internatnal Val (DFIV)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Covington Trust Enhanced Intl (FENI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for Pallas Capital Advisors

Top funds holding Neumora Therapeutics

Softbank Group Corp
Vanguard Group
MIC Capital Management UK
Siren
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
Millennium Management
T. Rowe Price Investment Management
Johnson & Johnson
BlackRock
Tang Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Neumora Therapeutics